HIGD1A and neoplasm: HIGD1A weakens oxidative stress during hypoxia and glucose deficiency by activating the AMPK pathway, inhibiting mitochondrial respiration, reducing ROS generation, and mediating cell dormancy, alleviating tumor cell death (14, 15, 69).